» Articles » PMID: 34670559

DEL in China: the D Antigen Among Serologic RhD-negative Individuals

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2021 Oct 21
PMID 34670559
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Providing RhD-negative red cell transfusions is a challenge in East Asia, represented by China, Korea, and Japan, where the frequency of RhD-negative is the lowest in the world.

Findings: Among 56 ethnic groups in China, the RhD-negative frequency in Han, the prevalent ethnicity, is 0.5% or less, similar to most other ethnic groups. The Uyghur ethnic group has the highest reported RhD-negative frequency of up to 4.7%, as compared to 13.9% in the US. However, an estimated 7.15 million RhD-negative people live in China. The RhD-negative phenotype typically results from a loss of the entire RHD gene, causing the lack of the RhD protein and D antigen. The DEL phenotype carries a low amount of the D antigen and types as RhD-negative in routine serology. The DEL prevalence in RhD-negative individuals averages 23.3% in the Han, 17% in the Hui and 2.4% in the Uyghur ethnicities. The Asian type DEL, also known as RHD*DEL1 and RHD:c.1227G > A allele, is by far the most prevalent among the 13 DEL alleles observed in China.

Conclusion: The purpose of this review is to summarize the data on DEL and to provide a basis for practical strategy decisions in managing patients and donors with DEL alleles in East Asia using molecular assays.

Citing Articles

DEL phenotype in RhD-negative North Indian blood donors.

Kaur P, Bedi R, Sood T, Mittal K, Kaur G Asian J Transfus Sci. 2024; 18(1):16-20.

PMID: 39036686 PMC: 11259341. DOI: 10.4103/ajts.ajts_127_23.


A Bioinformatically Initiated Approach to Evaluate GATA1 Regulatory Regions in Samples with Weak D, Del, or D- Phenotypes Despite Normal Exons.

McGowan E, Wu P, Hellberg A, Lopez G, Hyland C, Olsson M Transfus Med Hemother. 2024; 51(4):252-264.

PMID: 39021419 PMC: 11250534. DOI: 10.1159/000538469.


Single-exon fetal RHD genotyping: a 31-month follow up in the obstetric population of Western Sweden.

Pardi C, Hellberg A, Isakson P Blood Transfus. 2024; 22(5):387-394.

PMID: 38814881 PMC: 11390609. DOI: 10.2450/BloodTransfus.741.


Prevalence of ABO and Rhesus (D) Blood Group and Allelic Frequency at Blood Bank of Nigist Eleni Mohammed Hospital, Ethiopia.

Lendabo F, Srinivasan V, Rather R Biomed Res Int. 2024; 2024:5353528.

PMID: 38628500 PMC: 11019571. DOI: 10.1155/2024/5353528.


Two Cases of Anti-D Alloimmunization in D-Negative Thai Patients as a Result of the Asian-Type DEL on Transfused Red Cells.

Suksard K, Luangtrakool K, Rungroung T, Chamsai S, Saetam P, Kittisares K Transfus Med Hemother. 2024; 51(2):122-125.

PMID: 38584693 PMC: 10996056. DOI: 10.1159/000533625.


References
1.
Shao C, Su Y, Kohler M, Legler T . Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang. 2002; 83(2):156-61. DOI: 10.1046/j.1423-0410.2002.00192.x. View

2.
Chen J, Lin T, Chen Y, Wang Y, Jin Y, Yue C . RHD 1227A is an important genetic marker for RhD(el) individuals. Am J Clin Pathol. 2004; 122(2):193-8. DOI: 10.1309/3XMF-2NV5-707T-JE7X. View

3.
Yu X, Wagner F, Witter B, Flegel W . Outliers in RhD membrane integration are explained by variant RH haplotypes. Transfusion. 2006; 46(8):1343-51. DOI: 10.1111/j.1537-2995.2006.00902.x. View

4.
Westhoff C . Blood group genotyping. Blood. 2019; 133(17):1814-1820. DOI: 10.1182/blood-2018-11-833954. View

5.
Issitt P, Telen M . D, weak D (Du), and partial D: the molecular story unfolds. Transfusion. 1996; 36(2):97-100. DOI: 10.1046/j.1537-2995.1996.36296181917.x. View